131 related articles for article (PubMed ID: 17934522)
1. Decreased CHK protein levels are associated with Src activation in colon cancer cells.
Zhu S; Bjorge JD; Cheng HC; Fujita DJ
Oncogene; 2008 Mar; 27(14):2027-34. PubMed ID: 17934522
[TBL] [Abstract][Full Text] [Related]
2. PTP1B contributes to the oncogenic properties of colon cancer cells through Src activation.
Zhu S; Bjorge JD; Fujita DJ
Cancer Res; 2007 Nov; 67(21):10129-37. PubMed ID: 17974954
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of the Csk homologous kinase facilitates phosphorylation of Akt/PKB in MCF-7 cells.
Zagozdzon R; Bougeret C; Fu Y; Avraham HK
Int J Oncol; 2002 Dec; 21(6):1347-52. PubMed ID: 12429987
[TBL] [Abstract][Full Text] [Related]
4. Decreased tumorigenicity of a human colon adenocarcinoma cell line by an antisense expression vector specific for c-Src.
Staley CA; Parikh NU; Gallick GE
Cell Growth Differ; 1997 Mar; 8(3):269-74. PubMed ID: 9056668
[TBL] [Abstract][Full Text] [Related]
5. CHK negatively regulates Lyn kinase and suppresses pancreatic cancer cell invasion.
Fu Y; Zagozdzon R; Avraham R; Avraham HK
Int J Oncol; 2006 Dec; 29(6):1453-8. PubMed ID: 17088984
[TBL] [Abstract][Full Text] [Related]
6. C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)--endogenous negative regulators of Src-family protein kinases.
Chong YP; Mulhern TD; Cheng HC
Growth Factors; 2005 Sep; 23(3):233-44. PubMed ID: 16243715
[TBL] [Abstract][Full Text] [Related]
7. Csk homologous kinase associates with RAFTK/Pyk2 in breast cancer cells and negatively regulates its activation and breast cancer cell migration.
McShan GD; Zagozdzon R; Park SY; Zrihan-Licht S; Fu Y; Avraham S; Avraham H
Int J Oncol; 2002 Jul; 21(1):197-205. PubMed ID: 12063569
[TBL] [Abstract][Full Text] [Related]
8. Translocation of the Csk homologous kinase (Chk/Hyl) controls activity of CD36-anchored Lyn tyrosine kinase in thrombin-stimulated platelets.
Hirao A; Hamaguchi I; Suda T; Yamaguchi N
EMBO J; 1997 May; 16(9):2342-51. PubMed ID: 9171348
[TBL] [Abstract][Full Text] [Related]
9. Csk-homologous kinase (Chk) is an efficient inhibitor of Src-family kinases but a poor catalyst of phosphorylation of their C-terminal regulatory tyrosine.
Advani G; Lim YC; Catimel B; Lio DSS; Ng NLY; Chüeh AC; Tran M; Anasir MI; Verkade H; Zhu HJ; Turk BE; Smithgall TE; Ang CS; Griffin M; Cheng HC
Cell Commun Signal; 2017 Aug; 15(1):29. PubMed ID: 28784162
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of Csk homologous kinase (CHK) in normal brain and brain tumors.
Kim SO; Avraham S; Jiang S; Zagozdzon R; Fu Y; Avraham HK
Cancer; 2004 Sep; 101(5):1018-27. PubMed ID: 15329911
[TBL] [Abstract][Full Text] [Related]
11. CHK down-regulates SCF/KL-activated Lyn kinase activity in Mo7e megakaryocytic cells.
Price DJ; Rivnay B; Avraham H
Biochem Biophys Res Commun; 1999 Jun; 259(3):611-6. PubMed ID: 10364466
[TBL] [Abstract][Full Text] [Related]
12. Butyrate regulates the expression of c-Src and focal adhesion kinase and inhibits cell invasion of human colon cancer cells.
Lee JC; Maa MC; Yu HS; Wang JH; Yen CK; Wang ST; Chen YJ; Liu Y; Jin YT; Leu TH
Mol Carcinog; 2005 Aug; 43(4):207-14. PubMed ID: 16001424
[TBL] [Abstract][Full Text] [Related]
13. The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation.
Kanou T; Oneyama C; Kawahara K; Okimura A; Ohta M; Ikeda N; Shintani Y; Okumura M; Okada M
Mol Cancer Res; 2011 Jan; 9(1):103-14. PubMed ID: 21156787
[TBL] [Abstract][Full Text] [Related]
14. c-Yes tyrosine kinase activity in human colon carcinoma.
Park J; Meisler AI; Cartwright CA
Oncogene; 1993 Oct; 8(10):2627-35. PubMed ID: 7690925
[TBL] [Abstract][Full Text] [Related]
15. Csk-binding protein (Cbp) negatively regulates epidermal growth factor-induced cell transformation by controlling Src activation.
Jiang LQ; Feng X; Zhou W; Knyazev PG; Ullrich A; Chen Z
Oncogene; 2006 Sep; 25(40):5495-506. PubMed ID: 16636672
[TBL] [Abstract][Full Text] [Related]
16. Carboxyl-terminal Src kinase homologous kinase negatively regulates the chemokine receptor CXCR4 through YY1 and impairs CXCR4/CXCL12 (SDF-1alpha)-mediated breast cancer cell migration.
Lee BC; Lee TH; Zagozdzon R; Avraham S; Usheva A; Avraham HK
Cancer Res; 2005 Apr; 65(7):2840-5. PubMed ID: 15805285
[TBL] [Abstract][Full Text] [Related]
17. Csk homologous kinase (CHK), unlike Csk, enhances MAPK activation via Ras-mediated signaling in a Src-independent manner.
Zagozdzon R; Kaminski R; Fu Y; Fu W; Bougeret C; Avraham HK
Cell Signal; 2006 Jun; 18(6):871-81. PubMed ID: 16168623
[TBL] [Abstract][Full Text] [Related]
18. Structural elements and allosteric mechanisms governing regulation and catalysis of CSK-family kinases and their inhibition of Src-family kinases.
Ia KK; Mills RD; Hossain MI; Chan KC; Jarasrassamee B; Jorissen RN; Cheng HC
Growth Factors; 2010 Oct; 28(5):329-50. PubMed ID: 20476842
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the N-terminal unique domain of Chk tyrosine kinase in Chk-induced tyrosine phosphorylation in the nucleus.
Nakayama Y; Kawana A; Igarashi A; Yamaguchi N
Exp Cell Res; 2006 Jul; 312(12):2252-63. PubMed ID: 16707123
[TBL] [Abstract][Full Text] [Related]
20. The pro-apoptotic protein Prostate Apoptosis Response Protein-4 (Par-4) can be activated in colon cancer cells by treatment with Src inhibitor and 5-FU.
Kline CL; Irby RB
Apoptosis; 2011 Dec; 16(12):1285-94. PubMed ID: 21910008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]